repebis.upch.edu.perepebis.upch.edu.pe/articulos/acta.cancerol/v21n2/a4.pdf · RESUME N El Régimen FEM (Fluoruracil - Epidoxorubicina - Mitomicina) fué evaluado en 19 pacientes

Page 1 <img data-url='document/resume-n-el-rgimen-fem-fluoruracil-epidoxorubicina-mitomicina-fu-evaluado.html?page=1' data-page='1' class='cut-thumb lazyload' alt='Page 1: repebis.upch.edu.perepebis.upch.edu.pe/articulos/acta.cancerol/v21n2/a4.pdf · RESUME N El Régimen FEM (Fluoruracil - Epidoxorubicina - Mitomicina) fué evaluado en 19 pacientes' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader042.cupdf.com/reader042/viewer/2022041101/5ed8e6576714ca7f4768c76b/html5/thumbnails/1.jpg' width='140' height='200' /> Page 2 <img data-url='document/resume-n-el-rgimen-fem-fluoruracil-epidoxorubicina-mitomicina-fu-evaluado.html?page=2' data-page='2' class='cut-thumb lazyload' alt='Page 2: repebis.upch.edu.perepebis.upch.edu.pe/articulos/acta.cancerol/v21n2/a4.pdf · RESUME N El Régimen FEM (Fluoruracil - Epidoxorubicina - Mitomicina) fué evaluado en 19 pacientes' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader042.cupdf.com/reader042/viewer/2022041101/5ed8e6576714ca7f4768c76b/html5/thumbnails/2.jpg' width='140' height='200' /> Page 3 <img data-url='document/resume-n-el-rgimen-fem-fluoruracil-epidoxorubicina-mitomicina-fu-evaluado.html?page=3' data-page='3' class='cut-thumb lazyload' alt='Page 3: repebis.upch.edu.perepebis.upch.edu.pe/articulos/acta.cancerol/v21n2/a4.pdf · RESUME N El Régimen FEM (Fluoruracil - Epidoxorubicina - Mitomicina) fué evaluado en 19 pacientes' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader042.cupdf.com/reader042/viewer/2022041101/5ed8e6576714ca7f4768c76b/html5/thumbnails/3.jpg' width='140' height='200' /> Page 4 <img data-url='document/resume-n-el-rgimen-fem-fluoruracil-epidoxorubicina-mitomicina-fu-evaluado.html?page=4' data-page='4' class='cut-thumb lazyload' alt='Page 4: repebis.upch.edu.perepebis.upch.edu.pe/articulos/acta.cancerol/v21n2/a4.pdf · RESUME N El Régimen FEM (Fluoruracil - Epidoxorubicina - Mitomicina) fué evaluado en 19 pacientes' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader042.cupdf.com/reader042/viewer/2022041101/5ed8e6576714ca7f4768c76b/html5/thumbnails/4.jpg' width='140' height='200' /> Page 5 <img data-url='document/resume-n-el-rgimen-fem-fluoruracil-epidoxorubicina-mitomicina-fu-evaluado.html?page=5' data-page='5' class='cut-thumb lazyload' alt='Page 5: repebis.upch.edu.perepebis.upch.edu.pe/articulos/acta.cancerol/v21n2/a4.pdf · RESUME N El Régimen FEM (Fluoruracil - Epidoxorubicina - Mitomicina) fué evaluado en 19 pacientes' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader042.cupdf.com/reader042/viewer/2022041101/5ed8e6576714ca7f4768c76b/html5/thumbnails/5.jpg' width='140' height='200' /> Page 6 <img data-url='document/resume-n-el-rgimen-fem-fluoruracil-epidoxorubicina-mitomicina-fu-evaluado.html?page=6' data-page='6' class='cut-thumb lazyload' alt='Page 6: repebis.upch.edu.perepebis.upch.edu.pe/articulos/acta.cancerol/v21n2/a4.pdf · RESUME N El Régimen FEM (Fluoruracil - Epidoxorubicina - Mitomicina) fué evaluado en 19 pacientes' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader042.cupdf.com/reader042/viewer/2022041101/5ed8e6576714ca7f4768c76b/html5/thumbnails/6.jpg' width='140' height='200' />

repebis.upch.edu.perepebis.upch.edu.pe/articulos/acta.cancerol/v21n2/a4.pdf · RESUME N El Régimen FEM (Fluoruracil - Epidoxorubicina - Mitomicina) fué evaluado en 19 pacientes

Documents